Westfield Capital Management
WST icon

Westfield Capital Management’s West Pharmaceutical WST Stock Holding History

Westfield Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,700
Closed -$463K – 256
2019
Q2 		$463K Hold
3,700
– – ﹤0.01% 231
2019
Q1 		$408K Hold
3,700
– – ﹤0.01% 232
2018
Q4 		$363K Hold
3,700
– – ﹤0.01% 236
2018
Q3 		$457K Hold
3,700
– – ﹤0.01% 237
2018
Q2 		$367K Buy
+3,700
New +$341K ﹤0.01% 238
2018
Q1 		– Sell
-3,700
Closed -$365K – 267
2017
Q4 		$365K Hold
3,700
– – ﹤0.01% 237
2017
Q3 		$356K Buy
+3,700
New +$335K ﹤0.01% 237

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return